XTalks

MAY 1, 2024

In an ambitious move set to redefine grocery shopping, Walmart announced the launch of bettergoods, its most significant private label brand introduction in two decades. The launch of bettergoods delivers on that customer need in a meaningful way.” Photo courtesy of Walmart. percent in 2023 and is projected to drop to around 1.3

Branding 52

Branding Production Sales Marketing 52

Pharmaceutical Technology

DECEMBER 15, 2022

Based on the previous 7MM report, growth in the cardiomyopathies market was primarily attributed to the market release of Bristol Myers Squibb’s Camzyos (mavacamten) and the upcoming launch of Cytokinetics’ aficamten, both of which are myosin inhibitors indicated for the management of obstructive hypertrophic cardiomyopathy (HCM).

Marketing 130

Marketing Sales Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

JULY 22, 2022

ACTIV was stood up in about a month, launching on April 17, 2020, to develop a coordinated research response to speed COVID-19 treatment and vaccine options. ACTIV, COVID-19, FNIH. Key Points. The normal timeline for public-private partnerships is around 9 months of planning. The team reviewed 800 candidates over 2 years time.

Vaccination 130

Vaccination Vaccine Clinical Trials Clinical Trials 130

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. COVID-19 has not impacted the number of launches in the oncology space, as 2020 and 2021 have seen similar rates of drug launches as in 2019.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

Pharmaceutical Technology

NOVEMBER 9, 2022

In its October 28 quarterly Securities and Exchange Commission (SEC) filing, the company said that Roctavian’s commercial launch is now underway. Since its FDA approval in August 2022, the beta-thalassemia therapy was launched in the US with a $2.8 million price tag. million ($1.5 million ($1.8 million at the time).

Gene Therapy 278

Gene Therapy Gene FDA Approval Medicine 278

STAT News

OCTOBER 6, 2022

million tag as cost effective for a Bluebird Bio drug called Zynteglo for the blood disorder beta thalassemia, Arbuckle said in an interview. Bluebird also recently said it would charge $3 million for Skysona, the gene therapy it just launched for a rare brain-wasting disease. Continue to STAT+ to read the full story…

Gene Therapy 98

Gene Therapy Gene Insulin Drugs 98

Pharmaceutical Technology

JANUARY 17, 2023

Mounjaro is anticipated to launch in the US later this year or by early 2024. Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies. Bimagrumab is an activin receptor type 2B (ACVR2B or EC 2.7.11.30) antagonist that offers a unique mechanism of action within the obesity market.

Development 130

Development Compliance Trials Marketing 130

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Drug Delivery 52

Drug Delivery Manufacturing Drugs Marketing 52

Rethinking Clinical Trials

MAY 10, 2023

All of Us will expand the data available for participants, launch ancillary studies as a core and scalable capability, establish a diverse global community of 10,000 researchers, and incorporate participant return of value into data collections and assess its impact. We want to make sure that we are not an off ramp for clinical trials.

Medicine 130

Medicine Research Clinical Trials Clinical Trials 130

pharmaphorum

JANUARY 24, 2022

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. For its part, IBM has said that the Watson for Oncology product has been improving year-on-year as the AI crunches more and more data.

Radiology 111

Radiology Marketing Genome Genomics 111

Rethinking Clinical Trials

MARCH 28, 2023

is funded by PCORI and was launched almost 10 years ago. As the network was launched and the first trial, ADAPTABLE, was getting started, we came to the conclusion that we needed large, generalizable studies that were efficient. We have significantly improved the process of working with sites to collect and refine the data over time.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

FEBRUARY 14, 2024

DCP planned to launch 5 sites in the first year starting with the Boston Healthcare System. Tags #pctGR, @Collaboratory1 The post Grand Rounds February 9, 2024: Pragmatic Recruitment of Underrepresented Groups – Experience From the Diuretic Comparison Project (Cynthia Hau, MPH) appeared first on Rethinking Clinical Trials.

Clinical Trials 152

Clinical Trials Clinical Trials Cardiology Trials 152

pharmaphorum

AUGUST 21, 2022

The FDA has cleared Auvelity (dextromethorphan/bupropion) for the treatment of major depressive disorder (MDD) in adults, setting up a launch in the fourth quarter of this year.

Drugs 98

Drugs FDA Approval Production Marketing 98

XTalks

NOVEMBER 3, 2022

Eli Lilly is finding itself in an enviable position with its newly launched diabetes injection Mounjaro (tirzepatide) and blockbuster diabetes med Trulicity due to temporary shortages of competitor Novo Nordisk’s diabetes drug Ozempic (semaglutide). Lilly is also looking to pitch Mounjaro as an obesity drug and directly take on Novo’s Wegovy.

Sales 98

Sales FDA Approval Production Insulin 98

Rethinking Clinical Trials

MAY 19, 2023

Later this year, the study team will launch the COACH trial, a pragmatic clinical trial with 550 adult primary care patients with uncontrolled hypertension who are portal users. From there, the team iterated based on patient-physician needs, resulting in the COACH (Collaborative Oriented Approach to Controlling High Blood Pressure) app.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. —- End —-.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Rethinking Clinical Trials

AUGUST 30, 2023

There was a big gap between when the dashboard was built and launched. Tags #pctGR, @Collaboratory1 The post Grand Rounds August 25, 2023: Pragmatic Trial of an EHR Application to Display Real-time PRO Data: Successes and Challenges (Gabriela Schmajuk, MD, MS) appeared first on Rethinking Clinical Trials.

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

Rethinking Clinical Trials

OCTOBER 11, 2023

I wish that those of us involved had enough bandwidth to get involved with every major initiative that NHLBI launches, but that’s unfortunately not possible. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 6, 2023: Hybrid Studies Should Not Sacrifice Rigorous Methods (David M.

Clinical Trials 152

Clinical Trials Clinical Trials Trials Research 152

XTalks

OCTOBER 6, 2023

So, what justifies such a hefty price tag and are RXBars healthy? In 2013, lifelong friends Peter Rahal and Jared Smith launched RXBars, rapidly becoming a favorite choice for those seeking convenient and clean protein.

Protein 59

Protein Packaging Packaging Containment 59

The Pharma Data

DECEMBER 3, 2020

Utilizing Clover’s proprietary Trimer-Tag © technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag © Technology. Trimer-Tag © is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. About Dynavax. About CEPI.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

pharmaphorum

JANUARY 21, 2022

This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

DECEMBER 12, 2022

Vyvgart is already approved to treat generalised myasthenia gravis, getting a green light for that indication from the FDA a year ago, and launched with a $225,000 per annum price tag in competition with rival gMG drugs like AstraZeneca/Alexion’s C5 inhibitor Soliris (eculizumab).

Sales 52

Sales Trials Drugs Antibody 52

Rethinking Clinical Trials

FEBRUARY 9, 2023

The number of testing rounds, as well as the quality of usability testing, was critical in understanding workflows and the best moment to launch the tool. With every iteration of testing, the team worked to identify barriers in provider workflow. The team also engaged with a diverse array of providers from multiple hospitals and specialties.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

APRIL 5, 2022

Kimmtrak has launched in the US with an annual price tag of around $400,000 a year, reflecting the small target population, and analysts at GlobalData think that could help drive sales above $100 million – a sizeable figure for a small company like Immunocore with no other approved drugs.

Sales 52

Sales Protein Drugs Trials 52

XTalks

FEBRUARY 8, 2024

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.

Life Science 105

Life Science Marketing Branding Drugs 105

XTalks

JUNE 28, 2023

million price tag of Elevidys, a one-time gene therapy. Ingram expects the launch to take a few months to pick up due to logistical and policy issues. In a media call, Sarepta CEO Douglas Ingram revealed the $3.2 He said an analysis suggested that the drug could be cost-effective at $5 million.

Gene Therapy 98

Gene Therapy Gene Protein FDA Approval 98

pharmaphorum

APRIL 14, 2022

million price tag. The gene therapy has already been approved for marketing in the EU and UK, where it was launched at a cost of around $1.7 The FDA is currently reviewing beti-cel – also known as Zynteglo (betibeglogene autotemcel) – as a treatment for patients with beta thalassaemia who require regular blood transfusions.

Gene Therapy 64

Gene Therapy Gene Marketing Clinical Trials 64

XTalks

APRIL 18, 2024

Roche and Eli Lilly announced their partnership to develop the assay last year in March, which included launching a two-year clinical trial involving hundreds of volunteers. Previously, Roche secured an FDA breakthrough tag for another one of its Alzheimer’s blood tests that detects levels of pTau-181 and ApoE4 (apolipoprotein e4).

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

XTalks

JANUARY 28, 2022

The company is expecting approval from the European Medicines Agency (EMA) soon as it prepares for a European launch in the second quarter of this year. Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. The median treatment time is about 23 weeks (or 5.3

FDA Approval 98

FDA Approval Development Licensing Licensing 98

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Development 52

Development Drugs Clinical Development Antibody 52

XTalks

OCTOBER 28, 2021

Brave Robot debuted in 2020 with the launch of its ice cream and has since sold more than one million pints. While demand for vegan baking ingredients is on the rise, especially among Gen Z and millennial consumers, they remain specialty items and command larger price tags — the Climate Hero Super Cake is no exception.

Protein 98

Protein Packaging Packaging DNA 98

XTalks

JANUARY 7, 2022

In November of last year, a better-for-you macaroni and cheese called Goodles was launched on its direct-to-consumer (DTC) website. Outside the pasta space, but still in the carb space, California-based startup Better Brands launched the Better Bagel , a low-carb, high protein bagel that harnessed the power of food tech. .

Protein 52

Protein Marketing Containment Branding 52

pharmaphorum

AUGUST 18, 2022

bluebird has opted to launch it at a cost of $2.8 million price tag attached to the therapy when it was first made available in Europe, and is also well above the proposed $2.1 million, which compares to the $1.7 million level that cost-effectiveness organisation ICER said would be acceptable in a July report.

Gene Therapy 52

Gene Therapy FDA Approval Gene Clinical Trials 52

pharmaphorum

NOVEMBER 24, 2022

Despite J&J’s high hopes for the drug, sales have remained low, not warranting a mention in any of J&J’s quarterly financial updates since launch, and the company will look to the new data to try to encourage take-up.

Trials 52

Trials Sales Drugs Marketing 52

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. About CEPI.

Vaccination 52

Vaccination Vaccine Trials Protein 52

Rethinking Clinical Trials

SEPTEMBER 22, 2022

With the success of DANFLU-1, the team is launching the fully powered DANFLU-2 trial, which will be conducted the next two years, randomizing 208,000 patients over two flu seasons. The team will send out 800,000 invitations. Learn more. Read about DANFLU-1. pctGR, @Collaboratory1.

Trials 130

Trials Cardiology Vaccination Vaccine 130

pharmaphorum

DECEMBER 17, 2021

Aduhelm (aducanumab) was approved by the FDA in June, but has been held back by a glacial rollout as clinicians have questioned the data on which the decision to clear the drug was based, plus a $56,000 per year price tag, which has in turn led to pushback by payers.

Trials 52

Trials Sales Marketing FDA Approval 52